As pharma companies bolster their pipelines via multibillion-dollar acquisitions, drug manufacturers continue to heavily invest in the oncology space.

Oncology is one of the most exciting areas in healthcare, as novel therapies continue to emerge that move forward our molecular understanding of the disease and offer effective treatment advances. This Q&A explores oncology innovation with Kantar’s Stephanie Hawthorne, Vice President of Oncology and Specialty Therapeutics.

MedAdNews spoke to Bill Dreitlein, Senior Director, Pipeline & Drug Surveillance at OptumRx, about the state of the industry’s prescription drug pipeline and what enticing prospects will soon emerge.

Trust is a requirement in any successful relationship. Given the high stakes involved in creating successful pharma brands, building – or rebuilding – trusting client/agency relationships is worth a little extra effort.

In response to the growing need for data and technology-based solutions in the health and wellness categories, Havas Health & You (HH&Y) expanded the company’s offerings

CMI/Compas created a Growth & Innovation practice that is expected to keep clients ahead of the curve by prioritizing and investing in innovation.

Fingerpaint acquired La Jolla, Calif.-based market access and commercialization firm 1798, and announced a new partnership with Thrive Global aimed at educating employees through personal health and wellness content and empowering them with the tools they need to improve productivity and manage stress.

Med Ad News spoke with Christian Heidbreder, Ph.D., Chief Scientific Officer of Indivior Inc., about some of the barriers to patients seeking treatment for opioid use disorder, how to integrate treatment for opioid use disorder and infectious disease services, and the company’s efforts to provide treatments for those struggling with the disorder.

W2O made three strategic acquisitions in October/November 2019 to expand the company’s capabilities. Now part of W2O are Arcus Medica; ISO.health; and Radius Digital Science.

Jay Carter, R.Ph., was elected chair of the executive committee of the Coalition for Healthcare Communication for 2020-2021.